KB Home
KBH
Strategy
MSTR
D.R. Horton
DHI
4
Meritage Homes
MTH
5
Adobe
ADBE
US Stock MarketDetailed Quotes
BOLD Boundless Bio
- 1.630
- +0.030+1.88%
Trading Apr 30 12:56 ET
36.35MMarket Cap-0.56P/E (TTM)
1.660High1.540Low22.53KVolume1.590Open1.600Pre Close35.92KTurnover0.16%Turnover RatioLossP/E (Static)22.30MShares12.26052wk High0.24P/B23.13MFloat Cap1.06052wk Low--Dividend TTM14.19MShs Float15.240Historical High--Div YieldTTM7.50%Amplitude1.060Historical Low1.594Avg Price1Lot Size
About Boundless Bio Company
Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in San Diego, CA.
Company Profile
SymbolBOLD
Company NameBoundless Bio
Listing DateMar 28, 2024
Issue Price16.00
Founded2018
CEOMr. Zachary D. Hornby
MarketNASDAQ
Employees64
Fiscal Year Ends12-31
AddressAlexandria Way,Suite 100
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code10955
Phone1-858-766-9912
Websitehttp://www.boundlessbio.com
Company Executives
- Name
- Position
- Salary
- Zachary D. Hornby
- President, Chief Executive Officer and Director
- 2.37M
- Jessica Oien
- Chief Legal Officer and Corporate Secretary
- --
- Christian Hassig, PhD
- Chief Business Officer
- 903.51K
- Dr. James L. Freddo,M.D.
- Interim Chief Medical Officer
- --
- David A. Hinkle
- Treasurer, Principal Financial Officer and Principal Accounting Officer
- --
- Dr. Jonathan E. Lim,M.D.
- Chairman of the Board
- 61.17K
- Dr. Jakob Loven, PhD
- Independent Director
- --
- Dr. Fabio Pucci, PhD
- Independent Director
- --
- Kristina M. Burow
- Independent Director
- --
- Jennifer Lew
- Independent Director
- 66.55K
- Dr. Nancy C. Whiting, Pharm.D.
- Independent Director
- 102.74K
- Dr. James Christensen, PhD
- Independent Director
- 102.74K
- Dr. Christine Brennan, PhD
- Independent Director
- --
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call